Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 435

1.
2.

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.

Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M; VAESCO-GBS Case-Control Study Group..

BMJ. 2011 Jul 12;343:d3908. doi: 10.1136/bmj.d3908.

3.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group..

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8.

PMID:
23498095
5.

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.

Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222.

6.

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.

Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, Shneerson J, Verity C.

BMJ. 2013 Feb 26;346:f794. doi: 10.1136/bmj.f794.

7.

Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.

Örtqvist Å, Bennet R, Hamrin J, Rinder MR, Lindblad H, Öhd JN, Eriksson M.

Vaccine. 2015 May 21;33(22):2558-61. doi: 10.1016/j.vaccine.2015.04.011.

PMID:
25869891
8.

Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study.

Trotta F, Da Cas R, Spila Alegiani S, Gramegna M, Venegoni M, Zocchetti C, Traversa G.

BMJ. 2014 May 29;348:g3361. doi: 10.1136/bmj.g3361.

9.

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.

De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, Landry M, De Serres G.

JAMA. 2012 Jul 11;308(2):175-81. doi: 10.1001/jama.2012.7342.

PMID:
22782419
10.

Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.

Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, Hviid A.

BMJ. 2012 May 2;344:e2794. doi: 10.1136/bmj.e2794.

11.

Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010.

O'Flanagan D, Barret AS, Foley M, Cotter S, Bonner C, Crowe C, Lynch B, Sweeney B, Johnson H, McCoy B, Purcell E.

Euro Surveill. 2014 May 1;19(17):15-25.

12.

Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.

Ortqvist A, Bennet R, Rinder MR, Lindblad H, Eriksson M.

Vaccine. 2012 Aug 24;30(39):5699-702. doi: 10.1016/j.vaccine.2012.07.009.

PMID:
22819987
13.

A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two.

Moro ML, Nobilio L, Voci C, Di Mario S, Candela S, Magrini N; SaFoH1N1 working group..

Vaccine. 2013 Feb 27;31(10):1438-46. doi: 10.1016/j.vaccine.2012.07.090.

PMID:
22885015
14.

[Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].

Ormen B, Türker N, Vardar I, Kaptan F, El S, Ural S, Kaya F, Coşkun NA.

Mikrobiyol Bul. 2012 Jan;46(1):57-64. Turkish.

PMID:
22399172
15.

The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.

Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanström H, Mølgaard-Nielsen D, Heijbel H, Dahlström LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

Vaccine. 2013 Feb 6;31(8):1246-54. doi: 10.1016/j.vaccine.2012.12.015.

PMID:
23246544
16.
17.

The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.

Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH.

Vaccine. 2012 Mar 9;30(12):2168-72. doi: 10.1016/j.vaccine.2012.01.013. Erratum in: Vaccine. 2012 Oct 5;30(45):6508.

PMID:
22265861
18.
19.

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.

Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, Himanen SL, Hublin C, Julkunen I, Olsén P, Saarenpää-Heikkilä O, Kilpi T.

PLoS One. 2012;7(3):e33536. doi: 10.1371/journal.pone.0033536.

20.

Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.

Ghaderi S, Gunnes N, Bakken IJ, Magnus P, Trogstad L, Håberg SE.

Eur J Epidemiol. 2016 Jan;31(1):67-72. doi: 10.1007/s10654-015-0047-0.

PMID:
26008750
Items per page

Supplemental Content

Support Center